Shanghai Rendu Biotechnology Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is -1.64% vs 12.93% in Dec 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 61.29% vs -38.00% in Dec 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Dec'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "42.10",
          "val2": "42.80",
          "chgp": "-1.64%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1.50",
          "val2": "3.00",
          "chgp": "-50.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.20",
          "val2": "-0.60",
          "chgp": "133.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "5.00",
          "val2": "3.10",
          "chgp": "61.29%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "35.30%",
          "val2": "-37.70%",
          "chgp": "7.30%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is -9.33% vs 7.87% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 229.49% vs -193.98% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "160.30",
          "val2": "176.80",
          "chgp": "-9.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "10.60",
          "val2": "-18.70",
          "chgp": "156.68%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.30",
          "val2": "0.30",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "3.60",
          "val2": "-0.20",
          "chgp": "1,900.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "10.10",
          "val2": "-7.80",
          "chgp": "229.49%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-54.00%",
          "val2": "-216.40%",
          "chgp": "16.24%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ

Mar'26

Dec'25

Change(%)

Net Sales

42.10

42.80

-1.64%

Operating Profit (PBDIT) excl Other Income

1.50

3.00

-50.00%

Interest

0.00

0.00

Exceptional Items

0.20

-0.60

133.33%

Consolidate Net Profit

5.00

3.10

61.29%

Operating Profit Margin (Excl OI)

35.30%

-37.70%

7.30%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Mar 2026 is -1.64% vs 12.93% in Dec 2025

Consolidated Net Profit

QoQ Growth in quarter ended Mar 2026 is 61.29% vs -38.00% in Dec 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

160.30

176.80

-9.33%

Operating Profit (PBDIT) excl Other Income

10.60

-18.70

156.68%

Interest

0.30

0.30

Exceptional Items

3.60

-0.20

1,900.00%

Consolidate Net Profit

10.10

-7.80

229.49%

Operating Profit Margin (Excl OI)

-54.00%

-216.40%

16.24%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is -9.33% vs 7.87% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 229.49% vs -193.98% in Dec 2024

All Annual Results